Asset Manager

Updated:

Human Financial

Human Financial, founded by Andrew Sherman in 2017, runs a convex tail-hedge and volatility strategy that returned over 40% during the H1 2022 equity...

Human Financial

Human Financial was founded in 2017 by Andrew Sherman, a former macro trader with experience at institutions including Citadel. The firm concentrates exclusively on managing convex tail-hedge and volatility strategies for external capital, positioning itself as a specialist in portfolio protection rather than a broad multi-strategy hedge fund. Its mandate is to deliver crisis alpha without imposing the persistent negative carry historically associated with static put-buying programs. The firm deploys capital across global equity index options, fixed-income derivatives, and commodity volatility markets. Strategy construction blends a systematic signaling framework with discretionary trade execution across single-stock and index volatility surfaces. Core instruments include listed and OTC options on the S&P 500 and Euro Stoxx 50, VIX futures and options, and interest-rate swaptions. The firm targets asymmetric payoff profiles by structuring option portfolios that are heavily convex in equity market tail events while controlling theta bleed during range-bound regimes — a structural alternative to both trend-following and traditional option-writing programs. The geographic focus spans US and European derivatives exchanges. Human Financial operates from a single office in New York. The fund structure is an onshore-offshore master-feeder vehicle with managed accounts available for institutional allocators. The team is deliberately lean, built around Sherman’s research and execution discipline rather than sector-analyst coverage. In June 2022, Bloomberg reported that the Human Financial tail-hedge strategy had posted gains exceeding 40% during the first half of that year as equity markets repriced — a period that validated the firm's convexity-driven posture for existing limited partners (per Bloomberg, 2022). Unlike diversified hedge fund platforms that add a tail-hedge sleeve as a capital retention overlay, Human Financial exists solely to provide that sleeve to external portfolios. The firm does not offer long-only equity, credit, or macro-directional products. This purity of mandate reduces the agency risk that a tail-protection book will be compromised by a firm’s own long-side positioning. The governance model separates portfolio construction from asset-gathering incentives: the strategy has historically operated with a soft capacity ceiling, and Sherman has signaled a preference for closing to new capital once the opportunity set constrains targeted convexity.

General information

Firm type

Asset Manager

Year founded

2017

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Andrew Sherman

Founder & Chief Investment Officer

Sector focus

Hedge FundsSpecial Situations & Volatility

Frequently asked questions

Who runs investment decisions at Human Financial?

Andrew Sherman is the Founder and Chief Investment Officer, responsible for all portfolio construction and risk-taking decisions. His background includes macro and volatility trading at Citadel. The firm operates with a single decision-maker structure rather than an investment committee, which is consistent with its concentrated mandate in convex hedging and volatility arbitrage.

How does Human Financial manage the cost of carry in its tail-hedge program?

The firm structures option positions to maximize convexity per unit of premium spent, blending single-stock and index optionality with opportunistic volatility-surface arbitrage. It avoids the static, rolling long-put programs that generate persistent negative carry. Instead, Sherman’s process relies on a systematic signaling overlay that varies net exposure to volatility and tail-risk premia based on market-regime detection, seeking to reduce theta costs during low-volatility environments.

Does Human Financial participate in fund commitments or only direct investments?

Human Financial is a hedge fund manager that invests exclusively in liquid derivatives markets — primarily equity index options, VIX futures and options, swaptions, and commodity volatility instruments — not in private fund commitments. It does not allocate to third-party managers, private equity, venture capital, or credit funds. The vehicle is a direct investment fund available to external limited partners.

How is Human Financial structurally different from a multi-strategy hedge fund that offers tail protection?

The firm's singular focus on convex tail hedging removes the portfolio-level conflicts that arise when a multi-strategy platform runs a tail-protection book alongside large directional equity or credit exposures. Sherman does not manage long-only assets or competing alpha strategies, which means the tail-hedge mandate is not subordinated to other profit centers. This purity is rare among tail-risk managers, many of whom cross-subsidize their hedging books with premium-collecting strategies.

Which market environments does Human Financial's strategy explicitly target?

The strategy is designed to perform during sharp equity drawdowns and volatility-regime transitions — the type of environments witnessed in Q1 2020 and H1 2022. It does not seek returns from benign market beta or credit carry. The firm explicitly avoids constructing a portfolio that depends on a particular macroeconomic outlook, instead calibrating payoffs to the shape of the equity distribution's left tail.

What is Human Financial's capacity posture, and is the fund currently open?

Sherman has historically communicated a preference for managing a constrained asset base relative to the liquidity of the derivatives markets the firm trades. The strategy carries a soft capacity ceiling tied to the depth of listed and OTC option markets. The specific open-or-closed status at any given date requires confirmation from the firm's investor relations team, but the stated philosophy has been to prioritize performance integrity over asset accumulation.

Does Human Financial maintain philanthropic structures, and how are they separated?

No public record indicates that Human Financial operates a separate philanthropic foundation, donor-advised fund, or impact-investing vehicle associated with the management company. The firm appears structured exclusively as an investment manager for its pooled vehicle and managed accounts, without disclosed non-profit affiliates.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo